Loading provider…
Loading provider…
Dermatology Physician in Greenbrae, CA
NPI: 1003106014Primary Practice Location
Greenbrae Dermatology, a Medical Corporation
1300 S Eliseo Dr, Greenbrae, CA
Primary Employer
Greenbrae Dermatology, a Medical Corporation
greenbraedermatology.com
HQ Phone
Get MD Sinae's Phone Numberphone_androidMobile
Get MD Sinae's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2016 - 2025
NC State Medical License
2020 - 2025

American Board of Dermatology
Dermatology
Duke University Hospital
Chief Residency • Dermatology
2014 - 2015
Residency • Dermatology
2012 - 2015
Scripps Mercy Hospital
Internship • Transitional Year
2011 - 2012
UCSF School of Medicine
medschool.ucsf.edu
Medical School
Until 2011
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 17000Destruction of skin growth | 307 | 464 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 304 | 463 |
| 3 | 17003Destruction of 2-14 skin growths | 278 | 2,589 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 229 | 387 |
| 5 | 17110Destruction of up to 14 skin growths | 215 | 307 |
Early versus later presentations of venous malformations: where and why?
Authors: Tina Bhutani-Jacques, Christopher Dowd, Ari Kane
The role of 39 psoriasis risk variants on age of psoriasis onset.
Authors: Maya Debbaneh, Rishu Gupta, Ethan Levin, Theodora Mauro, Jillian Millsop
Publication Date: 2013-07-16
Lead Sponsor: Medipol University
Intervention / Treatment: DEVICE: a percussion massage gun, DEVICE: specially designed stainless-steel instruments
Lead Sponsor: University of Malaya
Intervention / Treatment: DEVICE: Conventional TBA, DEVICE: 3D TBA
Lead Sponsor: Intercept Pharmaceuticals
Intervention / Treatment: DRUG: Matching Placebo, DRUG: OCA